Cwm, LLC Caribou Biosciences, Inc. Transaction History

Cwm, LLC

$33.3 Billion
Q3 2025

A detailed history of Cwm, LLC transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Cwm, LLC holds 2,435 shares of CRBU stock, worth $7,012. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,435

Previous 33,839 92.8%

Holding current value

$7,012

Previous $43,000 86.05%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	SELL	$1.24 - $2.48 $38,940 - $77,881	-31,404 Reduced 92.8%	2,435 $6,000
Q2 2025 Jul 25, 2025	BUY	$0.73 - $1.42 $8,612 - $16,753	11,798 Added 53.53%	33,839 $43,000
Q1 2025 May 01, 2025	BUY	$0.88 - $1.88 $15,613 - $33,356	17,743 Added 412.82%	22,041 $20,000
Q4 2024 Feb 04, 2025	BUY	$1.59 - $2.79 $4,889 - $8,579	3,075 Added 251.43%	4,298 $7,000
Q3 2024 Oct 08, 2024	BUY	$1.56 - $2.73 $1,641 - $2,871	1,052 Added 615.2%	1,223 $2,000
Q2 2024 Jul 09, 2024	BUY	$1.62 - $5.05 $275 - $858	170 Added 17000.0%	171 $0
Q1 2024 Apr 05, 2024	BUY	$4.82 - $8.26 $4 - $8	1 New	1 $0

Others Institutions Holding CRBU

# of Institutions

132

Shares Held

43.5M

Call Options Held

25K

Put Options Held

53.2K

View Full List

About Caribou Biosciences, Inc.

Ticker CRBU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,840,800
Market Cap $175M
Description
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...

More about CRBU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account